JACC. Case reports
Immune Checkpoint Inhibitor-Associated Myocarditis Mimicking Takotsubo Cardiomyopathy.
Satoru Hiromasa, Yoshimichi Ueda, Takuya Mayumi, Hiroki Matsuoka, Tomoya Kaneda
Published: 202610.1016/j.jaccas.2025.106131
Abstract
BACKGROUND: Pembrolizumab-induced myocarditis is a rare but life-threatening immune-related adverse event. CASE SUMMARY: A 72-year-old woman with stage IV EGFR exon 19 deletion-positive left lung adenocarcinoma received osimertinib as first-line ther…
Preview only. Read the full abstract at the source